DNASE1 and cystic fibrosis: Deacon et al. designed a combination of tobramycin and Dornase alfa (recombinant human deoxyribonuclease I, DNase) to concurrently degrade thick DNA-rich mucus and enhance NP penetration into CF sputum [221].